These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 19242664

  • 1. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials].
    Zhang Z, Schmitt J, Wozel G, Kirch W.
    Med Klin (Munich); 2009 Feb 15; 104(2):125-36. PubMed ID: 19242664
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.
    Schmitt J, Zhang Z, Wozel G, Meurer M, Kirch W.
    Br J Dermatol; 2008 Sep 15; 159(3):513-26. PubMed ID: 18627372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K, Burden AD, Eaton JN, Hawkins NS.
    Br J Dermatol; 2012 Jan 15; 166(1):179-88. PubMed ID: 21910698
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.
    Signorovitch JE, Betts KA, Yan YS, LeReun C, Sundaram M, Wu EQ, Mulani P.
    Br J Dermatol; 2015 Feb 15; 172(2):504-12. PubMed ID: 25288183
    [Abstract] [Full Text] [Related]

  • 7. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N.
    Health Technol Assess; 2011 Feb 15; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [Abstract] [Full Text] [Related]

  • 8. Economic evaluation of systemic therapies for moderate to severe psoriasis.
    Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH.
    Br J Dermatol; 2009 Jun 15; 160(6):1264-72. PubMed ID: 19120346
    [Abstract] [Full Text] [Related]

  • 9. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
    Weinberg JM.
    Clin Ther; 2003 Oct 15; 25(10):2487-505. PubMed ID: 14667953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy of TNF-alpha antagonists for plaque-type psoriasis: a systematic review and graphical presentation].
    Levy-Roy A, Porcher R, de Fonclare AL, Morel P, Dupuy A.
    Ann Dermatol Venereol; 2009 Apr 15; 136(4):315-22. PubMed ID: 19361697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biological treatments for moderate-to-severe psoriasis: indirect comparison.
    Galván-Banqueri M, Marín Gil R, Santos Ramos B, Bautista Paloma FJ.
    J Clin Pharm Ther; 2013 Apr 15; 38(2):121-30. PubMed ID: 23442134
    [Abstract] [Full Text] [Related]

  • 17. Biologic therapies for psoriasis. A systematic review.
    Boehncke WH, Prinz J, Gottlieb AB.
    J Rheumatol; 2006 Jul 15; 33(7):1447-51. PubMed ID: 16724367
    [Abstract] [Full Text] [Related]

  • 18. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ, Bello-Quintero CE.
    J Manag Care Pharm; 2004 Jul 15; 10(4):318-25. PubMed ID: 15298530
    [Abstract] [Full Text] [Related]

  • 19. Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
    Tada Y, Watanabe R, Noma H, Kanai Y, Nomura T, Kaneko K.
    J Dermatol Sci; 2020 Jul 15; 99(1):53-61. PubMed ID: 32600737
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients.
    Brunasso AM, Puntoni M, Salvini C, Delfino C, Curcic P, Gulia A, Massone C.
    Acta Derm Venereol; 2011 Jan 15; 91(1):44-9. PubMed ID: 21088813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.